Patent directory · USPTO A61K / A61P
Patents matching “anti-”
1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
WO 2025198916
ANTICORPS ANTI-TAU
granted -
US 12421292
Anti-DLL3 chimeric antigen receptors and uses thereof
granted -
US 12421308
Anti-G-CSF antibodies and uses thereof
granted -
US 12421317
Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonist antibodies
granted -
US 12415867
Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof
granted -
WO 2025186043
FORMULATION PHARMACEUTIQUE POUR ANTICORPS ANTI-CCR8
granted -
US 12403167
Phenylethanoid glycoside extract from Acanthus ilicifolius L., preparation method thereof and use as anti-liver injury medicament
granted -
US 12398123
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria
granted -
US 12391750
Anti-C1S antibodies and methods of use thereof
granted -
US 12391742
Anti-KRAS-G12D T cell receptors
granted -
US 12384853
Anti-HER2/PD1 bispecific antibody
granted -
US 12384845
Activatable masked anti-CTLA4 binding proteins
granted -
US 12383572
Administration of an anti-activin-a compound to a subject
granted -
US 12378193
Anti-arrhythmicity agents
granted -
US 12377068
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 12371434
MLL1 inhibitors and anti-cancer agents
granted -
US 12371499
Method of treating cancer using anti-AV8 antibodies
granted -
US 12370264
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject
granted -
US 12371506
Subcutaneous administration of anti-CD38 antibodies
granted -
US 12365723
Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS
granted -
US 12365729
Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis
granted -
US 12357586
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
granted -
US 12357703
Muscle-targeting complexes comprising an anti-transferin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping
granted -
US 12357617
Discovery of novel anti-infectives for gram negative pathogens
granted